Company Page

Unlearn

Unlearn is an AI company that creates digital twins of clinical trial participants using machine learning to enable smaller, faster, and more efficient clinical trials. The company's Digital Twin Generators forecast individual patient health outcomes under control or standard of care, allowing pharmaceutical and biotech companies to reduce control arm sizes, accelerate enrollment, and bring new treatments to patients sooner. Unlearn's PROCOVA method is qualified by the European Medicines Agency and aligns with FDA guidance for use in phase 2 and 3 trials.

Company Founded in 2017